Your browser doesn't support javascript.
loading
Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker.
Klettner, Alexa; Tholey, Andreas; Wiegandt, Alena; Richert, Elisabeth; Nölle, Bernhard; Deuschl, Günther; Roider, Johann; Schneider, Susanne A.
  • Klettner A; Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Tholey A; Systematic Proteomics & Bioanalytics, Inst. Experimental Medicine, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
  • Wiegandt A; Systematic Proteomics & Bioanalytics, Inst. Experimental Medicine, Christian-Albrechts-Universität zu Kiel, Kiel, Germany.
  • Richert E; Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Nölle B; Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Deuschl G; Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Roider J; Department of Ophthalmology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Schneider SA; Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Mov Disord ; 32(3): 459-462, 2017 03.
Article en En | MEDLINE | ID: mdl-27859598
ABSTRACT

BACKGROUND:

We previously showed that the protein pattern of lenses removed in cataract surgery differs between patients with Parkinson's disease and age-matched controls. In this study, we identified the protein reduced in abundance in the 34- to 37-kDa gel band.

METHODS:

During cataract surgery (phacoemulsification), we collected the rinsing fluid and lens particles from the eyes of PD patients and controls. Residual lens fragments in the supernatant of 3 PD patients and aged-matched controls were studied for protein profiles using liquid chromatography-mass spectrometry and Western blots.

RESULTS:

We identified glyceraldehyde-3-phosphate dehydrogenase by mass spectrometry as the protein reduced in abundance and verified this finding in Western blots.

CONCLUSIONS:

Glyceraldehyde-3-phosphate dehydrogenase has been implicated in PD development. The reduction of glyceraldehyde-3-phosphate dehydrogenase in the lenses of PD patients may be a new biomarker for PD and might also indicate an important role for this protein in PD development. © 2016 International Parkinson and Movement Disorder Society.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Gliceraldehído-3-Fosfato Deshidrogenasa (Fosforilante) / Cristalino Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Gliceraldehído-3-Fosfato Deshidrogenasa (Fosforilante) / Cristalino Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2017 Tipo del documento: Article